Mutations leading to overexpression of TERT enhance the invasiveness of tumor cells, are more prevalent in older patients with invasive diseases and advanced tumor stages, and are associated with significantly shorter patient survival time [31]. The gene discussed is TERT; the disease is neoplasm.